What is the dosage form of this medicine?

The product is a solid tablet intended for oral administration.

Metronidazole Tablet

Name: Metronidazole Tablet
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 2259027935

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.80

1,000,000 Pieces

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Model NO.

200mg

Suitable for

Elderly, Adult

State

Solid

Shape

Tablet

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Transport Package

Cartons

Specification

200mg

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Key features

Trusted Manufacturer: Established in 1948 with over 4000 employees and USD 170 million capital.

GMP Certified: Manufactured with GMP approval by SFDA of China for quality assurance.

Global Export Experience: Products exported to South America, Africa, Asia, and Oceania since 2002.

High Production Capacity: Annual output exceeds 3 billion units for small volume injections.

Diverse Product Range: Capable of manufacturing 7 series medicines with over 100 specifications.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤15hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.